RESPONSE TO NIVOLUMAB AS ≥3rd LINE THERAPY IN PTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN'S LYMPHOMA (CHL) AND ITS IMPACT ON QUALITY OF LIFE IN RESPONDERS AND NONRESPONDERS
In: Hematological oncology, Jg. 37 (2019), S. 495-495
Online
serialPeriodical
Zugriff:
Titel: |
RESPONSE TO NIVOLUMAB AS ≥3rd LINE THERAPY IN PTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN'S LYMPHOMA (CHL) AND ITS IMPACT ON QUALITY OF LIFE IN RESPONDERS AND NONRESPONDERS
|
---|---|
Autor/in / Beteiligte Person: | Lepik, K. ; Mikhaylova, N. ; Kondakova, E. ; Tsvetkova, L. ; Zalyalov, Y. ; Borzenkova, E. ; Moiseev, I. ; Baykov, V. ; Nikitina, T. ; Porfir'eva, N. ; Ionova, T. ; Afanasyev, B. |
Link: | |
Zeitschrift: | Hematological oncology, Jg. 37 (2019), S. 495-495 |
Veröffentlichung: | 2019 |
Medientyp: | serialPeriodical |
ISSN: | 0278-0232 (print) |
Sonstiges: |
|